Trials / Conditions / Acute Lymphoblastic Leukemia Recurrent
Acute Lymphoblastic Leukemia Recurrent
5 registered clinical trials studyying Acute Lymphoblastic Leukemia Recurrent — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia NCT07371403 | King Hussein Cancer Center | N/A |
| Terminated | CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL NCT04049383 | Medical College of Wisconsin | Phase 1 |
| Completed | Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/R NCT03957915 | Institut Paoli-Calmettes | EARLY_Phase 1 |
| Active Not Recruiting | MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM) NCT03853616 | Miltenyi Biomedicine GmbH | Phase 1 |
| Terminated | International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic NCT03705507 | University of Birmingham | Phase 1 / Phase 2 |